Balance Sheet

v3.23.1

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Mar. 31, 2022
Current assets:
Cash and cash equivalents	$ 376,532	$ 493,817
Accounts receivable	700	12,229
Prepaid expenses and other current assets	26,916	6,253
Income tax receivable	185	632
Total current assets	404,333	512,931
Operating lease right-of-use assets	1,172	2,303
Property and equipment, net	333	330
Total assets	405,838	515,564
Current liabilities:
Accounts payable	1,353	18,629
Accrued expenses	40,421	24,575
Current portion of operating lease liabilities	1,173	1,145
Due to Roivant Sciences Ltd.	350	171
Total current liabilities	43,297	44,520
Operating lease liabilities, net of current portion	47	1,219
Total liabilities	43,344	45,739
Commitments and contingencies (Note 10)
Stockholders’ equity:
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 130,329,863 shares issued and outstanding at March 31, 2023 and 500,000,000 shares authorized, 116,482,899 shares issued and outstanding at March 31, 2022	13	12
Additional paid-in capital	927,976	824,796
Accumulated other comprehensive income	852	404
Accumulated deficit	(566,347)	(355,387)
Total stockholders’ equity	362,494	469,825
Total liabilities and stockholders’ equity	405,838	515,564
Series A Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source